Revvity (RVTY) Net Cash Flow Growth (1y) (2010 - 2026)
Revvity (RVTY) Net Cash Flow Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn | -260.86% |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn | 73.93% |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn | 722.22% |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn | -115.29% |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn | -58.16% |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn | 73.12% |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn | -441.96% |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn | 84.25% |
| 10 | Revvity | 12.76 Bn | 11.90 Bn | 387.66 Mn | -23.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 5, 2026 | -23.99% |
| Dec 28, 2025 | -57.40% |
| Sep 28, 2025 | -83.75% |
| Jun 29, 2025 | -236.86% |
| Mar 30, 2025 | -143.20% |
| Dec 29, 2024 | 127.72% |
| Sep 29, 2024 | 52.30% |
| Jun 30, 2024 | 115.82% |
| Mar 31, 2024 | 136.61% |
| Dec 31, 2023 | -162.88% |
| Apr 2, 2023 | -335.04% |
| Apr 3, 2022 | -81.05% |
| Oct 3, 2021 | -1,022.02% |
| Jul 4, 2021 | -1,449.29% |
| Apr 4, 2021 | 4,323.07% |
| Jan 3, 2021 | 89.29% |
| Oct 4, 2020 | -86.70% |
| Jul 5, 2020 | 24.03% |
| Apr 5, 2020 | 145.87% |
| Dec 29, 2019 | -3,681.20% |